| Code | Description | Claims | Beneficiaries | Total Paid |
|---|
| 99285 |
Emergency department visit for the evaluation and management, high severity with immediate threat to life |
77,312 |
69,115 |
$35.28M |
| 99284 |
Emergency department visit for the evaluation and management, high severity |
95,763 |
88,694 |
$28.00M |
| 99283 |
Emergency department visit for the evaluation and management, moderate severity |
75,768 |
71,794 |
$18.53M |
| 74177 |
Computed tomography, abdomen and pelvis; with contrast material |
18,569 |
17,394 |
$11.72M |
| 99291 |
Critical care, evaluation and management of the critically ill patient, first 30-74 minutes |
6,497 |
5,835 |
$5.69M |
| 74176 |
Computed tomography, abdomen and pelvis; without contrast material |
9,942 |
9,181 |
$4.16M |
| 47562 |
|
1,101 |
1,039 |
$3.90M |
| 70450 |
Computed tomography, head or brain; without contrast material |
24,168 |
21,985 |
$3.06M |
| 44970 |
|
736 |
703 |
$2.59M |
| G0378 |
Hospital observation service, per hour |
76,659 |
35,747 |
$2.54M |
| 99282 |
Emergency department visit for the evaluation and management, low to moderate severity |
22,930 |
22,013 |
$2.30M |
| 70553 |
Magnetic resonance imaging, brain; without contrast material, followed by contrast material and further sequences |
2,349 |
2,248 |
$1.60M |
| C1713 |
Anchor/screw for opposing bone-to-bone or soft tissue-to-bone (implantable) |
1,554 |
1,428 |
$1.49M |
| 58571 |
|
316 |
285 |
$1.36M |
| 72125 |
Computed tomography, cervical spine; without contrast material |
7,744 |
7,125 |
$1.10M |
| 70496 |
|
2,061 |
1,904 |
$948K |
| 70551 |
Magnetic resonance imaging, brain; without contrast material |
2,882 |
2,665 |
$780K |
| 99213 |
Office or other outpatient visit for the evaluation and management of an established patient, low complexity |
7,703 |
6,731 |
$752K |
| 93306 |
Echocardiography, transthoracic, real-time with image documentation, with and without Doppler, complete |
4,099 |
3,822 |
$708K |
| 93458 |
|
317 |
280 |
$707K |
| 88305 |
Level IV - Surgical pathology, gross and microscopic examination |
7,897 |
5,401 |
$618K |
| 71275 |
Computed tomographic angiography, chest, with contrast material |
6,050 |
5,664 |
$545K |
| 74174 |
|
710 |
681 |
$518K |
| 93970 |
|
2,938 |
2,719 |
$488K |
| 96365 |
Intravenous infusion, for therapy, prophylaxis, or diagnosis; initial, up to 1 hour |
32,469 |
27,085 |
$464K |
| 80053 |
Comprehensive metabolic panel |
160,891 |
127,321 |
$456K |
| 36430 |
|
2,804 |
2,069 |
$411K |
| 78452 |
Myocardial perfusion imaging, tomographic (SPECT); multiple studies at rest and/or stress |
524 |
466 |
$407K |
| 99214 |
Office or other outpatient visit for the evaluation and management of an established patient, moderate complexity |
2,441 |
2,097 |
$361K |
| 58670 |
|
135 |
118 |
$344K |
| 75574 |
|
915 |
845 |
$340K |
| 70491 |
|
911 |
859 |
$329K |
| 99203 |
Office or other outpatient visit for the evaluation and management of a new patient, low complexity |
2,937 |
2,882 |
$327K |
| 72131 |
|
879 |
835 |
$309K |
| 11042 |
Debridement, subcutaneous tissue (includes epidermis, dermis, and subcutaneous tissue); first 20 sq cm |
1,915 |
1,064 |
$300K |
| 54161 |
|
266 |
254 |
$288K |
| 49083 |
|
1,461 |
734 |
$282K |
| 43239 |
Esophagogastroduodenoscopy, flexible, transoral; with biopsy, single or multiple |
1,665 |
1,609 |
$267K |
| 72146 |
|
922 |
838 |
$240K |
| 90378 |
|
475 |
413 |
$238K |
| J1745 |
Injection, infliximab, excludes biosimilar, 10 mg |
135 |
99 |
$232K |
| 99212 |
Office or other outpatient visit for the evaluation and management of an established patient, straightforward |
3,468 |
2,744 |
$228K |
| 95812 |
|
1,683 |
1,661 |
$228K |
| 80307 |
Drug test(s), presumptive, any number of drug classes; immunoassay |
34,637 |
29,173 |
$191K |
| 71250 |
|
1,877 |
1,749 |
$186K |
| 93798 |
|
3,050 |
448 |
$181K |
| 59025 |
Fetal non-stress test |
2,520 |
1,614 |
$180K |
| 96372 |
Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular |
37,270 |
24,376 |
$157K |
| 93971 |
|
4,916 |
4,479 |
$156K |
| 87633 |
Infectious agent detection by nucleic acid, respiratory virus, 12-25 targets |
1,739 |
1,683 |
$142K |
| U0003 |
Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, making use of high throughput technologies as described by cms-2020-01-r |
7,604 |
7,221 |
$139K |
| 70486 |
|
2,603 |
2,441 |
$133K |
| 70487 |
|
263 |
257 |
$127K |
| 99215 |
Prolong outpt/office vis |
949 |
850 |
$126K |
| L8699 |
Prosthetic implant, not otherwise specified |
206 |
188 |
$118K |
| A9585 |
Injection, gadobutrol, 0.1 ml |
2,166 |
2,033 |
$115K |
| 80320 |
|
24,031 |
21,876 |
$114K |
| J1756 |
Injection, iron sucrose, 1 mg |
2,828 |
1,187 |
$113K |
| 93005 |
Electrocardiogram, routine ECG with at least 12 leads; tracing only, without interpretation and report |
72,096 |
56,161 |
$104K |
| 96374 |
Therapeutic, prophylactic, or diagnostic injection; intravenous push, single or initial substance |
67,126 |
58,978 |
$104K |
| 77012 |
|
145 |
116 |
$101K |
| 96413 |
Chemotherapy administration, intravenous infusion; up to 1 hour, single or initial substance |
3,777 |
2,174 |
$101K |
| 88307 |
|
2,288 |
1,731 |
$98K |
| 96366 |
Intravenous infusion, for therapy, prophylaxis, or diagnosis; each additional hour |
10,353 |
6,913 |
$93K |
| 95810 |
Polysomnography; sleep staging with 4 or more additional parameters |
126 |
124 |
$82K |
| 70498 |
|
2,069 |
1,919 |
$81K |
| 92611 |
|
494 |
465 |
$68K |
| 74455 |
|
260 |
256 |
$68K |
| 95816 |
|
578 |
555 |
$60K |
| 71260 |
Computed tomography, thorax, diagnostic; with contrast material |
2,601 |
2,378 |
$57K |
| C1769 |
Guide wire |
3,593 |
3,102 |
$56K |
| 96375 |
Therapeutic injection; each additional sequential IV push |
67,901 |
51,871 |
$55K |
| J1439 |
Injection, ferric carboxymaltose, 1 mg |
111 |
64 |
$54K |
| 96376 |
|
34,174 |
18,670 |
$49K |
| C1776 |
Joint device (implantable) |
74 |
67 |
$46K |
| 99204 |
Office or other outpatient visit for the evaluation and management of a new patient, moderate complexity |
260 |
255 |
$45K |
| 10060 |
|
691 |
665 |
$43K |
| 12001 |
|
2,027 |
1,944 |
$41K |
| 97110 |
Therapeutic procedure, each 15 minutes; therapeutic exercises to develop strength and endurance, flexibility and range of motion |
1,378 |
674 |
$38K |
| 12011 |
|
2,075 |
1,997 |
$35K |
| 72148 |
Magnetic resonance imaging, lumbar spine; without contrast material |
1,287 |
1,041 |
$34K |
| G0257 |
Unscheduled or emergency dialysis treatment for an esrd patient in a hospital outpatient department that is not certified as an esrd facility |
1,964 |
1,047 |
$34K |
| 93303 |
Transthoracic echocardiography for congenital cardiac anomalies, follow-up or limited study |
74 |
67 |
$33K |
| 86920 |
|
1,393 |
753 |
$32K |
| 82728 |
|
3,159 |
2,852 |
$31K |
| 76819 |
Fetal biophysical profile; without non-stress testing |
1,263 |
1,058 |
$31K |
| 96361 |
Intravenous infusion, hydration; each additional hour |
21,257 |
18,295 |
$30K |
| 96360 |
Intravenous infusion, hydration; initial, 31 minutes to 1 hour |
7,654 |
6,825 |
$27K |
| 74230 |
|
499 |
469 |
$25K |
| 76705 |
Ultrasound, abdominal, real time with image documentation; limited |
10,230 |
9,608 |
$25K |
| J2357 |
Injection, omalizumab, 5 mg |
346 |
92 |
$25K |
| 97113 |
|
367 |
112 |
$24K |
| 72141 |
|
1,241 |
1,072 |
$24K |
| 80048 |
Basic metabolic panel (calcium, ionized) |
32,258 |
24,301 |
$24K |
| 36561 |
|
14 |
13 |
$23K |
| J0696 |
Injection, ceftriaxone sodium, per 250 mg |
24,750 |
18,914 |
$23K |
| G0463 |
Hospital outpatient clinic visit for assessment and management of a patient |
3,170 |
1,360 |
$23K |
| 93976 |
|
6,563 |
6,096 |
$23K |
| 85025 |
Blood count; complete (CBC), automated, and automated differential WBC count |
172,166 |
137,835 |
$22K |
| 97112 |
Therapeutic procedure, each 15 minutes; neuromuscular reeducation of movement, balance, coordination |
498 |
182 |
$21K |
| C1889 |
Implantable/insertable device, not otherwise classified |
29 |
26 |
$21K |
| 76770 |
|
703 |
671 |
$20K |
| 97530 |
Therapeutic activities, direct patient contact, each 15 minutes |
8,574 |
4,295 |
$19K |
| 76775 |
|
2,251 |
2,097 |
$18K |
| 86923 |
|
3,296 |
1,715 |
$17K |
| 76815 |
Ultrasound, pregnant uterus, real time with image documentation, limited |
3,600 |
3,168 |
$17K |
| 12002 |
|
1,202 |
1,145 |
$16K |
| 20680 |
|
14 |
12 |
$15K |
| 71046 |
Radiologic examination, chest; 2 views |
20,270 |
18,952 |
$14K |
| 76805 |
Ultrasound, pregnant uterus, real time with image documentation, fetal and maternal evaluation |
404 |
382 |
$14K |
| 11045 |
|
20 |
12 |
$14K |
| 76856 |
Ultrasound, pelvic (nonobstetric), real time with image documentation; complete |
5,269 |
4,974 |
$13K |
| 95714 |
|
136 |
134 |
$13K |
| G0390 |
Trauma response team associated with hospital critical care service |
14 |
14 |
$13K |
| 97140 |
Manual therapy techniques, each 15 minutes (e.g., mobilization/manipulation, manual lymphatic drainage) |
615 |
178 |
$12K |
| 36591 |
|
4,257 |
2,447 |
$12K |
| C1781 |
Mesh (implantable) |
336 |
312 |
$12K |
| 96367 |
|
5,772 |
4,863 |
$12K |
| 82657 |
|
183 |
175 |
$11K |
| 45380 |
Colonoscopy, flexible; with biopsy, single or multiple |
109 |
108 |
$11K |
| 86850 |
|
12,182 |
10,837 |
$11K |
| 0225U |
|
298 |
294 |
$11K |
| 99281 |
Emergency department visit for the evaluation and management, self-limited or minor |
214 |
204 |
$11K |
| J0897 |
Injection, denosumab, 1 mg |
28 |
25 |
$10K |
| 11043 |
|
15 |
12 |
$9K |
| 82947 |
|
63,727 |
30,230 |
$9K |
| 71045 |
Radiologic examination, chest; single view |
47,720 |
42,565 |
$8K |
| 76700 |
Ultrasound, abdominal, real time with image documentation; complete |
482 |
455 |
$8K |
| 97161 |
|
4,493 |
3,910 |
$8K |
| C1894 |
Introducer/sheath, other than guiding, other than intracardiac electrophysiological, non-laser |
2,407 |
2,094 |
$8K |
| 97166 |
|
1,407 |
1,190 |
$6K |
| 73630 |
|
3,892 |
3,556 |
$6K |
| 97162 |
|
1,419 |
1,247 |
$6K |
| J3490 |
Unclassified drugs |
103,176 |
46,360 |
$6K |
| 87040 |
|
26,256 |
13,960 |
$6K |
| G0480 |
Drug test(s), definitive, utilizing (1) drug identification methods able to identify individual drugs and distinguish between structural isomers (but not necessarily stereoisomers), including, but not limited to gc/ms (any type, single or tandem) and lc/ms (any type, single or tandem and excluding immunoassays (e.g., ia, eia, elisa, emit, fpia) and enzymatic methods (e.g., alcohol dehydrogenase)), (2) stable isotope or other universally recognized internal standards in all samples (e.g., to control for matrix effects, interferences and variations in signal strength), and (3) method or drug-specific calibration and matrix-matched quality control material (e.g., to control for instrument variations and mass spectral drift); qualitative or quantitative, all sources, includes specimen validity testing, per day; 1-7 drug class(es), including metabolite(s) if performed |
3,135 |
2,773 |
$6K |
| 97165 |
|
2,098 |
1,843 |
$6K |
| 80329 |
|
3,114 |
2,759 |
$6K |
| 87086 |
Culture, bacterial; quantitative colony count, urine |
29,890 |
27,845 |
$6K |
| 88341 |
|
83 |
53 |
$6K |
| 29581 |
|
564 |
181 |
$5K |
| 87636 |
Infectious agent detection by nucleic acid; SARS-CoV-2 and influenza virus types A and B |
13,292 |
12,636 |
$5K |
| 76801 |
|
5,376 |
4,817 |
$5K |
| J8540 |
Dexamethasone, oral, 0.25 mg |
2,945 |
2,258 |
$5K |
| 74018 |
|
5,560 |
5,111 |
$5K |
| 84702 |
|
21,658 |
19,975 |
$5K |
| 97535 |
Self-care/home management training, each 15 minutes |
5,757 |
3,611 |
$5K |
| J2405 |
Injection, ondansetron hydrochloride, per 1 mg |
66,702 |
53,093 |
$5K |
| 92507 |
Treatment of speech, language, voice, communication, and/or auditory processing disorder |
75 |
34 |
$4K |
| 82805 |
|
2,417 |
2,139 |
$4K |
| 45378 |
Colonoscopy, flexible; diagnostic, including collection of specimen(s) |
13 |
12 |
$4K |
| 84484 |
|
58,621 |
34,332 |
$4K |
| 0450 |
Emergency room services |
89 |
76 |
$4K |
| 87491 |
Infectious agent detection by nucleic acid; Chlamydia trachomatis, amplified probe |
6,338 |
6,077 |
$4K |
| 87591 |
Infectious agent detection by nucleic acid; Neisseria gonorrhoeae, amplified probe |
6,385 |
6,115 |
$4K |
| 73610 |
|
3,649 |
3,323 |
$4K |
| 94640 |
Pressurized or nonpressurized inhalation treatment for acute airway obstruction |
18,323 |
12,082 |
$3K |
| 99211 |
Office or other outpatient visit for the evaluation and management of an established patient, minimal severity |
1,311 |
752 |
$3K |
| 76817 |
Ultrasound, pregnant uterus, real time with image documentation, transvaginal |
3,453 |
3,165 |
$3K |
| 84443 |
Thyroid stimulating hormone (TSH) |
13,492 |
12,180 |
$3K |
| 87631 |
|
8,365 |
8,077 |
$3K |
| 92526 |
|
101 |
56 |
$3K |
| 99195 |
|
58 |
56 |
$3K |
| 51600 |
|
260 |
257 |
$3K |
| 96523 |
|
185 |
160 |
$3K |
| 83690 |
|
44,244 |
39,239 |
$3K |
| 88304 |
|
3,271 |
3,062 |
$3K |
| 76830 |
Ultrasound, transvaginal |
3,182 |
3,027 |
$3K |
| 87075 |
|
1,280 |
966 |
$3K |
| Q9967 |
Low osmolar contrast material, 300-399 mg/ml iodine concentration, per ml |
33,054 |
30,061 |
$3K |
| 73562 |
|
5,309 |
4,613 |
$3K |
| 73130 |
|
3,442 |
3,151 |
$2K |
| 72100 |
|
3,064 |
2,840 |
$2K |
| 81025 |
|
15,878 |
14,950 |
$2K |
| 97163 |
|
15 |
13 |
$2K |
| 94762 |
|
5,267 |
3,403 |
$2K |
| 84703 |
|
27,479 |
25,530 |
$2K |
| J2765 |
Injection, metoclopramide hcl, up to 10 mg |
3,994 |
3,258 |
$2K |
| 73080 |
|
1,706 |
1,604 |
$2K |
| 95819 |
|
15 |
15 |
$2K |
| 81001 |
|
52,314 |
47,818 |
$2K |
| 73502 |
|
2,518 |
2,227 |
$2K |
| 72128 |
|
54 |
54 |
$1K |
| 73030 |
|
4,220 |
3,680 |
$1K |
| 83880 |
|
12,179 |
10,891 |
$1K |
| P9016 |
Red blood cells, leukocytes reduced, each unit |
1,842 |
1,409 |
$1K |
| J3475 |
Injection, magnesium sulfate, per 500 mg |
3,379 |
2,521 |
$1K |
| 93017 |
|
528 |
466 |
$1K |
| 76870 |
|
1,127 |
1,062 |
$1K |
| J2370 |
Injection, phenylephrine hcl, up to 1 ml |
2,230 |
1,752 |
$1K |
| 83735 |
|
32,499 |
24,557 |
$1K |
| 92610 |
|
63 |
53 |
$1K |
| 73110 |
|
2,378 |
2,149 |
$985.78 |
| 87635 |
Infectious agent detection by nucleic acid; SARS-CoV-2 (COVID-19), amplified probe |
4,487 |
4,366 |
$963.50 |
| C9113 |
Injection, pantoprazole sodium, per vial |
9,636 |
6,017 |
$946.67 |
| J8499 |
Prescription drug, oral, non chemotherapeutic, nos |
148,697 |
50,378 |
$911.09 |
| J1885 |
Injection, ketorolac tromethamine, per 15 mg |
34,976 |
28,969 |
$864.49 |
| M0243 |
Intravenous infusion or subcutaneous injection, casirivimab and imdevimab includes infusion or injection, and post administration monitoring |
267 |
258 |
$864.10 |
| 83605 |
|
20,379 |
15,173 |
$779.52 |
| 87661 |
Infectious agent detection by nucleic acid; Trichomonas vaginalis, amplified probe |
2,106 |
2,032 |
$722.52 |
| J2270 |
Injection, morphine sulfate, up to 10 mg |
38,495 |
26,659 |
$718.04 |
| 85610 |
|
29,547 |
24,218 |
$716.57 |
| 85027 |
|
23,058 |
17,486 |
$701.88 |
| 93880 |
|
126 |
106 |
$696.90 |
| 73090 |
|
2,769 |
2,352 |
$678.69 |
| 85384 |
|
1,553 |
1,319 |
$661.71 |
| 73140 |
|
939 |
877 |
$652.98 |
| G0379 |
Direct admission of patient for hospital observation care |
2,069 |
1,985 |
$635.12 |
| J7030 |
Infusion, normal saline solution , 1000 cc |
39,182 |
31,359 |
$632.85 |
| 87651 |
Infectious agent detection by nucleic acid; Streptococcus, group A, amplified probe |
2,555 |
2,500 |
$595.74 |
| J2704 |
Injection, propofol, 10 mg |
17,431 |
15,962 |
$583.47 |
| J0702 |
Injection, betamethasone acetate 3 mg and betamethasone sodium phosphate 3 mg |
365 |
203 |
$577.06 |
| 94760 |
|
14,474 |
8,098 |
$557.91 |
| 85730 |
|
12,860 |
11,292 |
$556.83 |
| 90715 |
|
3,424 |
3,276 |
$468.19 |
| 87880 |
Infectious agent antigen detection by immunoassay; Streptococcus, group A |
7,111 |
6,885 |
$461.68 |
| 86635 |
|
759 |
386 |
$459.48 |
| 73620 |
|
520 |
450 |
$458.82 |
| 87186 |
|
7,165 |
6,397 |
$454.77 |
| J1650 |
Injection, enoxaparin sodium, 10 mg |
13,231 |
6,792 |
$444.93 |
| 80061 |
Lipid panel |
3,153 |
2,814 |
$438.46 |
| 86900 |
|
14,643 |
13,271 |
$430.21 |
| 87210 |
|
6,929 |
6,614 |
$424.09 |
| 76882 |
|
269 |
252 |
$421.99 |
| 86901 |
|
14,831 |
13,424 |
$418.04 |
| 73590 |
|
2,695 |
2,356 |
$411.82 |
| 87088 |
|
17,135 |
15,277 |
$410.82 |
| J8597 |
Antiemetic drug, oral, not otherwise specified |
17,502 |
15,246 |
$410.07 |
| 72072 |
|
785 |
723 |
$408.96 |
| J3010 |
Injection, fentanyl citrate, 0.1 mg |
29,862 |
24,770 |
$402.68 |
| 87070 |
|
3,400 |
2,669 |
$390.00 |
| J0500 |
Injection, dicyclomine hcl, up to 20 mg |
1,984 |
1,851 |
$372.60 |
| 74021 |
|
3,749 |
3,609 |
$366.75 |
| 82784 |
|
264 |
153 |
$361.63 |
| J2543 |
Injection, piperacillin sodium/tazobactam sodium, 1 gram/0.125 grams (1.125 grams) |
6,225 |
3,211 |
$358.45 |
| 85379 |
|
3,176 |
2,936 |
$349.17 |
| A9270 |
Non-covered item or service |
163,961 |
17,887 |
$316.00 |
| 73600 |
|
315 |
263 |
$312.00 |
| J7120 |
Ringers lactate infusion, up to 1000 cc |
3,561 |
2,802 |
$301.04 |
| 73060 |
|
709 |
617 |
$299.17 |
| 81003 |
|
22,723 |
21,162 |
$297.46 |
| 76604 |
|
250 |
216 |
$292.91 |
| 73552 |
|
981 |
854 |
$291.15 |
| 84145 |
|
4,486 |
4,120 |
$280.61 |
| 84112 |
|
2,061 |
1,894 |
$279.88 |
| 85240 |
|
12 |
12 |
$270.64 |
| 87077 |
|
8,558 |
7,346 |
$258.22 |
| 74022 |
|
1,391 |
1,265 |
$247.84 |
| J0780 |
Injection, prochlorperazine, up to 10 mg |
4,332 |
3,964 |
$246.36 |
| 82731 |
|
187 |
181 |
$239.54 |
| 82550 |
|
10,892 |
8,817 |
$238.84 |
| J2930 |
Injection, methylprednisolone sodium succinate, up to 125 mg |
4,496 |
3,635 |
$236.00 |
| J1100 |
Injection, dexamethasone sodium phosphate, 1 mg |
21,745 |
19,443 |
$232.50 |
| 86140 |
|
11,899 |
10,938 |
$229.18 |
| 74420 |
|
84 |
72 |
$228.94 |
| 85460 |
|
748 |
682 |
$214.49 |
| 85055 |
|
4,861 |
2,837 |
$212.55 |
| J2785 |
Injection, regadenoson, 0.1 mg |
431 |
374 |
$212.47 |
| 97116 |
|
5,556 |
3,686 |
$198.36 |
| J1200 |
Injection, diphenhydramine hcl, up to 50 mg |
14,020 |
11,482 |
$193.30 |
| 87081 |
|
4,149 |
3,996 |
$190.84 |
| 90732 |
|
57 |
53 |
$190.60 |
| 82565 |
|
4,129 |
3,663 |
$187.87 |
| 83036 |
Hemoglobin; glycosylated (A1C) |
4,507 |
4,130 |
$181.45 |
| J1953 |
Injection, levetiracetam, 10 mg |
1,420 |
1,061 |
$166.96 |
| 73564 |
|
39 |
36 |
$161.12 |
| 88342 |
|
834 |
736 |
$151.77 |
| C2617 |
Stent, non-coronary, temporary, without delivery system |
68 |
57 |
$151.60 |
| 72170 |
|
1,478 |
1,338 |
$151.32 |
| J2920 |
Injection, methylprednisolone sodium succinate, up to 40 mg |
3,022 |
1,629 |
$141.41 |
| U0005 |
Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, cdc or non-cdc, making use of high throughput technologies, completed within 2 calendar days from date of specimen collection (list separately in addition to either hcpcs code u0003 or u0004) as described by cms-2020-01-r2 |
3,808 |
3,544 |
$139.88 |
| 62270 |
|
33 |
26 |
$136.80 |
| J2060 |
Injection, lorazepam, 2 mg |
7,608 |
5,983 |
$127.98 |
| 70360 |
|
144 |
142 |
$126.52 |
| 73120 |
|
390 |
333 |
$121.82 |
| 82248 |
|
260 |
210 |
$113.00 |
| C1758 |
Catheter, ureteral |
141 |
121 |
$112.94 |
| J0690 |
Injection, cefazolin sodium, 500 mg |
11,527 |
8,859 |
$112.55 |
| 84100 |
|
9,145 |
6,593 |
$111.68 |
| 72040 |
|
500 |
450 |
$108.13 |
| 90471 |
Immunization administration (includes percutaneous, intradermal, subcutaneous, or intramuscular injections), 1 vaccine |
3,833 |
3,650 |
$105.19 |
| J0360 |
Injection, hydralazine hcl, up to 20 mg |
5,149 |
3,483 |
$104.79 |
| 86870 |
|
72 |
55 |
$102.50 |
| 96368 |
|
1,501 |
1,295 |
$101.02 |
| J2550 |
Injection, promethazine hcl, up to 50 mg |
5,248 |
3,938 |
$98.32 |
| 84132 |
|
9,112 |
7,324 |
$93.33 |
| 86308 |
|
890 |
867 |
$92.26 |
| 51702 |
|
292 |
259 |
$91.64 |
| J3480 |
Injection, potassium chloride, per 2 meq |
4,676 |
3,168 |
$88.36 |
| 82607 |
|
1,501 |
1,352 |
$79.06 |
| 84466 |
|
2,828 |
2,597 |
$78.08 |
| 87502 |
Infectious agent detection by nucleic acid, influenza virus, for multiple types or subtypes, includes all targets |
660 |
607 |
$74.08 |
| 43235 |
|
16 |
13 |
$72.00 |
| 85046 |
|
2,622 |
2,246 |
$67.64 |
| 87449 |
|
957 |
785 |
$67.21 |
| J0295 |
Injection, ampicillin sodium/sulbactam sodium, per 1.5 gm |
2,369 |
1,366 |
$53.77 |
| 83615 |
|
1,524 |
1,193 |
$51.59 |
| J1940 |
Injection, furosemide, up to 20 mg |
3,161 |
1,986 |
$48.57 |
| 85014 |
|
3,489 |
2,901 |
$48.47 |
| J2360 |
Injection, orphenadrine citrate, up to 60 mg |
2,655 |
2,517 |
$48.36 |
| 71101 |
|
304 |
289 |
$47.94 |
| 86769 |
|
491 |
483 |
$42.96 |
| 85652 |
|
4,483 |
4,087 |
$41.73 |
| 82140 |
|
2,151 |
1,758 |
$39.55 |
| 84439 |
|
2,535 |
2,323 |
$39.35 |
| 87205 |
|
3,986 |
3,113 |
$38.84 |
| 87340 |
|
505 |
464 |
$37.17 |
| A9577 |
Injection, gadobenate dimeglumine (multihance), per ml |
138 |
134 |
$36.60 |
| 73070 |
|
398 |
325 |
$36.31 |
| 87427 |
|
408 |
210 |
$35.28 |
| J7040 |
Infusion, normal saline solution, sterile (500 ml = 1 unit) |
6,084 |
5,411 |
$33.38 |
| 86592 |
|
615 |
574 |
$32.80 |
| J0330 |
Injection, succinylcholine chloride, up to 20 mg |
3,249 |
2,994 |
$32.77 |
| J0456 |
Injection, azithromycin, 500 mg |
2,219 |
1,609 |
$32.41 |
| 82010 |
|
2,655 |
2,292 |
$32.10 |
| J1170 |
Injection, hydromorphone, up to 4 mg |
6,555 |
4,763 |
$31.67 |
| J7512 |
Prednisone, immediate release or delayed release, oral, 1 mg |
4,192 |
2,967 |
$31.49 |
| J1815 |
Injection, insulin, per 5 units |
17,541 |
7,245 |
$29.22 |
| 87045 |
|
549 |
526 |
$29.09 |
| 86803 |
|
132 |
128 |
$27.40 |
| J0692 |
Injection, cefepime hydrochloride, 500 mg |
1,519 |
955 |
$26.41 |
| J3535 |
Drug administered through a metered dose inhaler |
778 |
758 |
$25.99 |
| 82270 |
|
497 |
485 |
$25.27 |
| J1630 |
Injection, haloperidol, up to 5 mg |
2,175 |
1,765 |
$24.09 |
| 99152 |
|
2,062 |
1,859 |
$23.32 |
| 84156 |
|
2,328 |
1,877 |
$23.07 |
| 94761 |
|
622 |
390 |
$22.83 |
| 84460 |
|
1,279 |
1,139 |
$22.44 |
| 82570 |
|
426 |
371 |
$19.63 |
| J2710 |
Injection, neostigmine methylsulfate, up to 0.5 mg |
3,558 |
3,206 |
$19.56 |
| 82378 |
|
180 |
157 |
$19.33 |
| J2250 |
Injection, midazolam hydrochloride, per 1 mg |
16,349 |
14,988 |
$18.57 |
| J1644 |
Injection, heparin sodium, per 1000 units |
10,087 |
4,730 |
$18.01 |
| 83540 |
|
2,874 |
2,628 |
$17.29 |
| 82553 |
|
594 |
487 |
$16.65 |
| 94664 |
|
447 |
301 |
$15.32 |
| 82746 |
|
490 |
440 |
$14.52 |
| J3370 |
Injection, vancomycin hcl, 500 mg |
5,796 |
3,319 |
$14.40 |
| 73560 |
|
409 |
352 |
$14.07 |
| 84550 |
|
2,365 |
2,061 |
$12.30 |
| G0008 |
Administration of influenza virus vaccine |
1,175 |
1,068 |
$11.86 |
| 96415 |
|
1,605 |
986 |
$11.53 |
| 87147 |
|
1,050 |
951 |
$9.98 |
| 80164 |
|
1,185 |
1,006 |
$9.78 |
| 87807 |
|
431 |
421 |
$8.57 |
| 90686 |
|
1,217 |
1,106 |
$7.73 |
| 96417 |
|
512 |
307 |
$7.67 |
| 87116 |
|
323 |
245 |
$7.23 |
| 84295 |
|
3,688 |
3,216 |
$7.07 |
| J1642 |
Injection, heparin sodium, (heparin lock flush), per 10 units |
2,830 |
1,307 |
$6.96 |
| 82435 |
|
2,092 |
1,850 |
$6.67 |
| J2175 |
Injection, meperidine hydrochloride, per 100 mg |
4,914 |
4,538 |
$6.48 |
| 84520 |
|
3,681 |
3,264 |
$6.38 |
| J7999 |
Compounded drug, not otherwise classified |
2,451 |
2,247 |
$5.90 |
| 87102 |
|
423 |
332 |
$5.89 |
| 85018 |
|
5,612 |
4,531 |
$5.84 |
| 84450 |
|
584 |
510 |
$5.06 |
| J1790 |
Injection, droperidol, up to 5 mg |
939 |
894 |
$4.21 |
| 82945 |
|
336 |
273 |
$4.05 |
| J2469 |
Injection, palonosetron hcl, 25 mcg |
215 |
134 |
$3.91 |
| 84157 |
|
382 |
313 |
$3.77 |
| 84300 |
|
71 |
64 |
$3.50 |
| S0028 |
Injection, famotidine, 20 mg |
1,478 |
1,307 |
$3.13 |
| J1956 |
Injection, levofloxacin, 250 mg |
3,376 |
2,326 |
$1.78 |
| J7050 |
Infusion, normal saline solution, 250 cc |
960 |
674 |
$1.24 |
| 89051 |
|
1,703 |
1,113 |
$0.96 |
| 82330 |
|
1,474 |
1,285 |
$0.00 |
| J2371 |
Injection, phenylephrine hydrochloride, 20 micrograms |
635 |
575 |
$0.00 |
| 87276 |
|
58 |
54 |
$0.00 |
| 95700 |
|
187 |
184 |
$0.00 |
| J2795 |
Injection, ropivacaine hydrochloride, 1 mg |
156 |
147 |
$0.00 |
| 87206 |
|
506 |
320 |
$0.00 |
| P9040 |
Red blood cells, leukocytes reduced, irradiated, each unit |
257 |
191 |
$0.00 |
| J1836 |
Injection, metronidazole, 10 mg |
526 |
304 |
$0.00 |
| 86780 |
|
80 |
77 |
$0.00 |
| 76377 |
|
1,669 |
1,582 |
$0.00 |
| 80178 |
|
285 |
241 |
$0.00 |
| 82533 |
|
54 |
38 |
$0.00 |
| 99153 |
Mod sedat endo service >5yrs |
1,161 |
1,041 |
$0.00 |
| C9399 |
Unclassified drugs or biologicals |
212 |
188 |
$0.00 |
| G8988 |
Self care functional limitation, projected goal status, at therapy episode outset, at reporting intervals, and at discharge or to end reporting |
63 |
58 |
$0.00 |
| J2003 |
Injection, lidocaine hydrochloride, 1 mg |
275 |
245 |
$0.00 |
| 87046 |
|
257 |
239 |
$0.00 |
| J3411 |
Injection, thiamine hcl, 100 mg |
177 |
96 |
$0.00 |
| J0571 |
Buprenorphine, oral, 1 mg |
32 |
13 |
$0.00 |
| J2470 |
Injection, pantoprazole sodium, 40 mg |
422 |
308 |
$0.00 |
| J1920 |
Injection, labetalol hydrochloride, 5 mg |
228 |
166 |
$0.00 |
| 36415 |
Collection of venous blood by venipuncture |
341 |
297 |
$0.00 |
| J7042 |
5% dextrose/normal saline (500 ml = 1 unit) |
67 |
54 |
$0.00 |
| 97010 |
|
177 |
56 |
$0.00 |
| 93320 |
|
59 |
54 |
$0.00 |
| J3360 |
Injection, diazepam, up to 5 mg |
71 |
61 |
$0.00 |
| 87015 |
|
73 |
50 |
$0.00 |
| G8987 |
Self care functional limitation, current status, at therapy episode outset and at reporting intervals |
61 |
56 |
$0.00 |
| 90632 |
|
14 |
14 |
$0.00 |
| C1725 |
Catheter, transluminal angioplasty, non-laser (may include guidance, infusion/perfusion capability) |
81 |
76 |
$0.00 |
| 77001 |
|
45 |
42 |
$0.00 |
| 74019 |
|
145 |
145 |
$0.00 |
| U0002 |
2019-ncov coronavirus, sars-cov-2/2019-ncov (covid-19), any technique, multiple types or subtypes (includes all targets), non-cdc |
18 |
18 |
$0.00 |
| G0009 |
Administration of pneumococcal vaccine |
44 |
41 |
$0.00 |
| 87280 |
|
16 |
12 |
$0.00 |
| 87632 |
|
42 |
41 |
$0.00 |
| 87184 |
|
54 |
48 |
$0.00 |
| 83930 |
|
43 |
38 |
$0.00 |
| 73660 |
|
52 |
49 |
$0.00 |
| 83021 |
|
13 |
13 |
$0.00 |
| J2001 |
Injection, lidocaine hcl for intravenous infusion, 10 mg |
86 |
76 |
$0.00 |
| 87389 |
Infectious agent antigen detection by immunoassay technique, HIV-1 antigen with HIV-1 and HIV-2 antibodies |
16 |
13 |
$0.00 |
| 94644 |
|
17 |
15 |
$0.00 |
| Q9963 |
High osmolar contrast material, 350-399 mg/ml iodine concentration, per ml |
13 |
13 |
$0.00 |
| 82306 |
Vitamin D; 25 hydroxy, includes fraction(s), if performed |
12 |
12 |
$0.00 |
| J1453 |
Injection, fosaprepitant, 1 mg |
40 |
25 |
$0.00 |
| J3105 |
Injection, terbutaline sulfate, up to 1 mg |
126 |
115 |
$0.00 |
| Q9958 |
High osmolar contrast material, up to 149 mg/ml iodine concentration, per ml |
417 |
411 |
$0.00 |
| A9575 |
Injection, gadoterate meglumine, 0.1 ml |
505 |
491 |
$0.00 |
| 87899 |
|
366 |
181 |
$0.00 |
| 87324 |
|
172 |
149 |
$0.00 |
| 73000 |
|
94 |
79 |
$0.00 |
| A9502 |
Technetium tc-99m tetrofosmin, diagnostic, per study dose |
543 |
479 |
$0.00 |
| 88112 |
|
623 |
478 |
$0.00 |
| J7510 |
Prednisolone oral, per 5 mg |
916 |
808 |
$0.00 |
| 82375 |
|
854 |
779 |
$0.00 |
| 85007 |
|
467 |
377 |
$0.00 |
| J0744 |
Injection, ciprofloxacin for intravenous infusion, 200 mg |
537 |
335 |
$0.00 |
| J0171 |
Injection, adrenalin, epinephrine, 0.1 mg |
549 |
499 |
$0.00 |
| J1596 |
Injection, glycopyrrolate, 0.1 mg |
200 |
198 |
$0.00 |
| 93325 |
|
595 |
549 |
$0.00 |
| G8978 |
Mobility: walking & moving around functional limitation, current status, at therapy episode outset and at reporting intervals |
237 |
188 |
$0.00 |
| 80074 |
|
133 |
117 |
$0.00 |
| 0042T |
|
142 |
133 |
$0.00 |
| C1760 |
Closure device, vascular (implantable/insertable) |
555 |
478 |
$0.00 |
| G8979 |
Mobility: walking & moving around functional limitation, projected goal status, at therapy episode outset, at reporting intervals, and at discharge or to end reporting |
262 |
208 |
$0.00 |
| C1887 |
Catheter, guiding (may include infusion/perfusion capability) |
542 |
467 |
$0.00 |
| 76937 |
|
172 |
159 |
$0.00 |
| J1171 |
Injection, hydromorphone, 0.1 mg |
103 |
84 |
$0.00 |
| 82365 |
|
13 |
12 |
$0.00 |
| J3371 |
Injection, vancomycin hcl (mylan), not therapeutically equivalent to j3370, 500 mg |
55 |
39 |
$0.00 |
| J0665 |
Injection, bupivicaine, not otherwise specified, 0.5 mg |
909 |
673 |
$0.00 |
| A9552 |
Fluorodeoxyglucose f-18 fdg, diagnostic, per study dose, up to 45 millicuries |
86 |
81 |
$0.00 |
| 87254 |
|
152 |
96 |
$0.00 |
| Q0245 |
Injection, bamlanivimab and etesevimab, 2100 mg |
78 |
74 |
$0.00 |
| M0245 |
Intravenous infusion, bamlanivimab and etesevimab, includes infusion and post administration monitoring |
76 |
72 |
$0.00 |
| 29125 |
|
186 |
177 |
$0.00 |
| J1580 |
Injection, garamycin, gentamicin, up to 80 mg |
121 |
92 |
$0.00 |
| Q0244 |
Injection, casirivimab and imdevimab, 1200 mg |
248 |
240 |
$0.00 |
| 80202 |
|
234 |
193 |
$0.00 |
| 73100 |
|
61 |
51 |
$0.00 |
| C1788 |
Port, indwelling (implantable) |
26 |
25 |
$0.00 |
| 76857 |
|
14 |
14 |
$0.00 |
| Q0114 |
Fern test |
446 |
412 |
$0.00 |
| J2919 |
Injection, methylprednisolone sodium succinate, 5 mg |
531 |
358 |
$0.00 |
| 93041 |
|
55 |
43 |
$0.00 |
| 82247 |
|
73 |
50 |
$0.00 |
| J2310 |
Injection, naloxone hydrochloride, per 1 mg |
28 |
26 |
$0.00 |
| 76000 |
|
29 |
27 |
$0.00 |
| J0736 |
Injection, clindamycin phosphate, 300 mg |
85 |
53 |
$0.00 |
| 96401 |
|
101 |
44 |
$0.00 |
| J0694 |
Injection, cefoxitin sodium, 1 gm |
79 |
52 |
$0.00 |
| 86789 |
|
14 |
14 |
$0.00 |
| J2720 |
Injection, protamine sulfate, per 10 mg |
17 |
12 |
$0.00 |
| 85347 |
|
24 |
16 |
$0.00 |
| 93975 |
|
12 |
12 |
$0.00 |
| 87275 |
|
58 |
54 |
$0.00 |
| J2800 |
Injection, methocarbamol, up to 10 ml |
12 |
12 |
$0.00 |
| Q9961 |
High osmolar contrast material, 250-299 mg/ml iodine concentration, per ml |
16 |
16 |
$0.00 |
| 85520 |
|
39 |
27 |
$0.00 |
| 88313 |
|
23 |
12 |
$0.00 |
| 94770 |
|
13 |
12 |
$0.00 |
| 87798 |
Infectious agent detection by nucleic acid; not otherwise specified, amplified probe, each organism |
29 |
25 |
$0.00 |
| C1729 |
Catheter, drainage |
43 |
37 |
$0.00 |
| 29515 |
|
12 |
12 |
$0.00 |
| A9537 |
Technetium tc-99m mebrofenin, diagnostic, per study dose, up to 15 millicuries |
19 |
12 |
$0.00 |
| 86788 |
|
14 |
14 |
$0.00 |
| C1874 |
Stent, coated/covered, with delivery system |
16 |
14 |
$0.00 |